Deltacortene



Indications and Reactions:

Role Indications Reactions
Secondary
Drug Use For Unknown Indication 21.4%
Product Used For Unknown Indication 12.7%
Renal Transplant 11.4%
Non-hodgkin's Lymphoma 10.9%
B-cell Lymphoma 9.0%
Diffuse Large B-cell Lymphoma 5.9%
Rheumatoid Arthritis 5.1%
Chronic Lymphocytic Leukaemia 3.3%
Anaplastic Large Cell Lymphoma T- And Null-cell Types Stage Iv 2.5%
Disseminated Large Cell Lymphoma 2.5%
High Grade B-cell Lymphoma Burkitt-like Lymphoma Recurrent 2.5%
Hypertension 2.5%
Type 2 Diabetes Mellitus 1.6%
Diabetes Mellitus 1.3%
Multiple Myeloma 1.3%
Non-hodgkin's Lymphoma Unspecified Histology Indolent Stage Iv 1.3%
Prophylaxis 1.3%
Psoriasis 1.3%
Atrial Fibrillation 1.1%
Plasma Cell Myeloma 1.1%
Thrombocytopenia 13.3%
Neutropenia 10.8%
Respiratory Failure 9.6%
Stomatitis 9.6%
Dermatomyositis 4.8%
Psychomotor Hyperactivity 4.8%
Sepsis 4.8%
International Normalised Ratio Increased 3.6%
Osteonecrosis 3.6%
Pancytopenia 3.6%
Pneumonia 3.6%
Pyrexia 3.6%
Renal Transplant 3.6%
Renal Tubular Necrosis 3.6%
Urinary Fistula 3.6%
Urinary Retention 3.6%
Anaemia 2.4%
Bronchopneumonia 2.4%
Cardiac Disorder 2.4%
Diabetes Mellitus 2.4%
Concomitant
Drug Use For Unknown Indication 27.2%
Product Used For Unknown Indication 19.5%
Rheumatoid Arthritis 11.1%
Premedication 4.9%
Hypertension 4.0%
Prophylaxis 4.0%
Non-small Cell Lung Cancer 3.5%
Hiv Infection 3.2%
Multiple Myeloma 3.1%
Non-hodgkin's Lymphoma 2.9%
Diffuse Large B-cell Lymphoma 2.3%
Colitis Ulcerative 2.2%
Metastases To Bone 2.1%
Breast Cancer 2.0%
Crohn's Disease 1.5%
Prophylaxis Against Gastrointestinal Ulcer 1.4%
Prostate Cancer Metastatic 1.4%
Plasma Cell Myeloma 1.3%
Pain 1.2%
Chronic Obstructive Pulmonary Disease 1.2%
Osteonecrosis 10.8%
Osteonecrosis Of Jaw 9.5%
Crohn's Disease 7.2%
Pyrexia 7.2%
Transaminases Increased 7.2%
Pulmonary Embolism 5.9%
Vomiting 5.9%
Stomatitis 5.4%
Thrombocytopenia 5.4%
Renal Failure Acute 5.0%
Syncope 4.5%
Respiratory Failure 3.6%
Pruritus 3.2%
Toxic Skin Eruption 3.2%
Cerebral Haemorrhage 2.7%
Intestinal Obstruction 2.7%
Loss Of Consciousness 2.7%
Lung Infection 2.7%
Oral Lichen Planus 2.7%
Sepsis 2.7%
Interacting
Product Used For Unknown Indication 72.7%
Chronic Obstructive Pulmonary Disease 9.1%
Pain In Extremity 9.1%
Prophylaxis 9.1%
Melaena 100.0%